Published online (ahead of print in the journal Annals of Neurology), the results of a new study found that one year after arterial ischaemic stroke (AIS), the rate of death, recurrence of stroke, and neurological impairment was lower than reports in previous studies.
Can a drug commonly used for gout improve recovery and prevention of further stroke for stroke survivors?
Torpor is a natural state of reduced energy use and body temperature. This research will look at the effect of torpor on brain activity and function, and the amount of brain damage caused by ischaemic stroke.
On February 11 2015, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
Pilot trial of devices to extract clot from occluded arteries (PISTE)
Two more studies support mechanical clot retrieval for stroke, named THERAPY and THRACE. Both presented their results at the European Stroke Organisation Conference (ESOC) in Glasgow.
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
This study will investigate whether reducing blood pressure can stop bleeding in the brain after thrombolysis (a clot-busting treatment for stroke) and improve patient's outcomes.
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
This fellowship aims to develop, tailor and target the delivery of a 6-week group intervention that offers educational, psychological and social support for people following TIA and minor stroke.